The Oncosearch | Oncotarget

A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia Priority Research Paper

Neil E. Kay, Paolo Strati, Betsy R. LaPlant, Jose F. Leis, Daniel Nikcevich, Timothy G. Call, Adam M. Pettinger, Connie E. Lesnick, Curtis A. Hanson, Tait D. Shanafelt

Published Nov 16, 2016 · Vol. 7, No. 48 · pp. 78269-78280

Prognostic value of total lesion glycolysis of baseline ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma Research Paper

Mingge Zhou, Yumei Chen, Honghui Huang, Xiang Zhou, Jianjun Liu, Gang Huang

Published Nov 7, 2016 · Vol. 7, No. 50 · pp. 83544-83553

A network meta-analysis for toxicity of eight chemotherapy regimens in the treatment of metastatic/advanced breast cancer Research Paper

Xiao-Hua Zhang, Shuai Hao, Bo Gao, Wu-Guo Tian, Yan Jiang, Shu Zhang, Ling-Ji Guo, Dong-Lin Luo

Published Nov 2, 2016 · Vol. 7, No. 51 · pp. 84533-84543

Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors Clinical Research Papers

Kieuhoa T. Vo, Erin E. Karski, Nicole M. Nasholm, Shelly Allen, Fabienne Hollinger, W. Clay Gustafson, Janel R. Long-Boyle, Stephen Shiboski, Katherine K. Matthay, Steven G. DuBois

Published Oct 25, 2016 · Vol. 8, No. 14 · pp. 23851-23861

Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era Research Paper

Seyoung Seo, Jung Yong Hong, Shinkyo Yoon, Changhoon Yoo, Ji Hyun Park, Jung Bok Lee, Chan-sik Park, Jooryung Huh, Yoonse Lee, Kyung Won Kim, Jin-Sook Ryu, Seok Jin Kim, Won Seog Kim, Dok Hyun Yoon, Cheolwon Suh

Published Oct 18, 2016 · Vol. 7, No. 47 · pp. 76934-76943

Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis Research Paper

Stefania Oliva, Manuela Gambella, Milena Gilestro, Vittorio Emanuele Muccio, Francesca Gay, Daniela Drandi, Simone Ferrero, Roberto Passera, Chiara Pautasso, Annalisa Bernardini, Mariella Genuardi, Francesca Patriarca, Elona Saraci, Maria Teresa Petrucci, Norbert Pescosta, Anna Marina Liberati, Tommaso Caravita, Concetta Conticello, Alberto Rocci, Pellegrino Musto, Mario Boccadoro, Antonio Palumbo, Paola OmedÃ¨

Published Oct 13, 2016 · Vol. 8, No. 4 · pp. 5924-5935

Acrolein preferentially damages nucleolus eliciting ribosomal stress and apoptosis in human cancer cells Research Paper

Hsiang-tsui Wang, Tzu-ying Chen, Ching-wen Weng, Chun-hsiang Yang, Moon-shong Tang

Published Oct 12, 2016 · Vol. 7, No. 49 · pp. 80450-80464

Response to apatinib in chemotherapy-failed advanced spindle cell breast carcinoma Case Report

Na Zhou, Congmin Liu, Helei Hou, Chuantao Zhang, Dong Liu, Guanqun Wang, Kewei Liu, Jingjuan Zhu, Hongying Lv, TianjJun Li, Xiaochun Zhang

Published Oct 11, 2016 · Vol. 7, No. 44 · pp. 72373-72379

Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study Research Paper

Seok Jin Kim, Jun Sik Hong, Myung Hee Chang, Jeong-A Kim, Jae-Yong Kwak, Jin Seok Kim, Dok Hyun Yoon, Won Sik Lee, Young Rok Do, Hye Jin Kang, Hyeon-Seok Eom, Yong Park, Jong-Ho Won, Yeung-Chul Mun, Hyo Jung Kim, Jung Hye Kwon, Jee Hyun Kong, Sung Yong Oh, Sunah Lee, Sung Hwa Bae, Deok-Hwan Yang, Hyun Jung Jun, Yang Soo Kim, Hwan Jung Yun, Soon Il Lee, Min Kyoung Kim, Eun Kyung Park, Won Seog Kim, Cheolwon Suh

Published Oct 4, 2016 · Vol. 7, No. 44 · pp. 72033-72043

A 5-day cytoreductive chemotherapy followed by haplo-identical hsct (FA5-BUCY) as a tumor-ablative regimen improved the survival of patients with advanced hematological malignancies Research Paper

Ting Yang, Qiaoxian Lin, Jinhua Ren, Ping Chen, Xiaohong Yuan, Xiaofeng Luo, Tingbo Liu, Jing Zheng, Zhihong Zheng, Xiaoyun Zheng, Xinji Chen, Langhui Zhang, Hao Zheng, Zaisheng Chen, Xueling Hua, Shaohua Le, Jian Li, Zhizhe Chen, Jianda Hu

Published Oct 1, 2016 · Vol. 7, No. 48 · pp. 78773-78786

A phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL Clinical Research Papers

Nitin Jain, Kumudha Balakrishnan, Alessandra Ferrajoli, Susan M. Oâ€™Brien, Jan A. Burger, Tapan M. Kadia, Jorge E. Cortes, Mary L. Ayres, Francesco Paolo Tambaro, Michael J. Keating, Varsha Gandhi, William G. Wierda

Published Sep 15, 2016 · Vol. 8, No. 13 · pp. 22104-22112

The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome Research Paper

Bozena Konopka, Lukasz Michal Szafron, Ewa Kwiatkowska, Agnieszka Podgorska, Aleksandra Zolocinska, Barbara Pienkowska-Grela, Agnieszka Dansonka-Mieszkowska, Anna Balcerak, Martyna Lukasik, Anna Stachurska, Agnieszka Timorek, Beata Spiewankiewicz, Mona El-Bahrawy, Jolanta Kupryjanczyk

Published Sep 2, 2016 · Vol. 7, No. 41 · pp. 67412-67424

Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer Research Paper

Andrea L.A. Wong, Raghav Sundar, Ting-Ting Wang, Thian-C Ng, Bo Zhang, Sing-Huang Tan, Thomas I.P. Soh, Angela S.L. Pang, Chee-Seng Tan, Samuel G.W. Ow, Lingzhi Wang, Jannet Mogro, Jingshan Ho, Anand D. Jeyasekharan, Yiqing Huang, Choon-Hua Thng, Ching-Wan Chan, Mikael Hartman, Philip Iau, Shaik A. Buhari, Boon-Cher Goh, Soo-Chin Lee

Published Aug 25, 2016 · Vol. 7, No. 39 · pp. 64089-64099

Genetic polymorphisms and response to 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients Research Paper

Karolina Tecza, Jolanta Pamula-Pilat, Joanna Lanuszewska, Ewa Grzybowska

Published Aug 4, 2016 · Vol. 7, No. 41 · pp. 66790-66808

PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas Research Paper

Renato Franco, GiosuÃ¨ Scognamiglio, Elena Valentino, Michela Vitiello, Antonio Luciano, Giuseppe Palma, Claudio Arra, Elvira La Mantia, Luigi Panico, Valentina Tenneriello, Antonello Pinto, Ferdinando Frigeri, Gaetana Capobianco, Gerardo Botti, Laura Cerchia, Annarosaria De Chiara, Monica Fedele

Published Aug 1, 2016 · Vol. 7, No. 37 · pp. 59158-59172

Thromboxane A2 receptor (TBXA2R) is a potent survival factor for triple negative breast cancers (TNBCs) Research Paper

Katy Orr, Niamh E. Buckley, Paula Haddock, Colin James, Jean-Luc Parent, Stephen McQuaid, Paul B. Mullan

Published Jul 30, 2016 · Vol. 7, No. 34 · pp. 55458-55472

Chemo-immunotherapy induces tumor regression in a mouse model of spontaneous mammary carcinogenesis Research Paper

Eleonora AricÃ², Paola Sestili, Giulia Carpinelli, Rossella Canese, Serena Cecchetti, Giovanna Schiavoni, Maria Teresa Dâ€™Urso, Filippo Belardelli, Enrico Proietti

Published Jul 28, 2016 · Vol. 7, No. 37 · pp. 59754-59765

Definitive activation of endogenous antitumor immunity by repetitive cycles of cyclophosphamide with interspersed Toll-like receptor agonists Research Paper

Soraya Zorro Manrique, Ana L. Dominguez, Noweeda Mirza, Christopher D. Spencer, Judy M. Bradley, James H. Finke, James J. Lee, Larry R. Pease, Sandra J. Gendler, Peter A. Cohen

Published Jun 21, 2016 · Vol. 7, No. 28 · pp. 42919-42942

BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma models Research Paper

Srikanth R. Ambati, Jae-Hung Shieh, Benet Pera, Eloisi Caldas Lopes, Anisha Chaudhry, Elissa W.P. Wong, Ashish Saxena, Tsann-Long Su, Malcolm A.S. Moore

Published May 29, 2016 · Vol. 7, No. 28 · pp. 43062-43075

Paclitaxel is necessary for improved survival in epithelial ovarian cancers with homologous recombination gene mutations Clinical Research Papers

Stephanie Jean, Jiaqi Li, Dionyssios Katsaros, Bradley Wubbenhorst, Kara N. Maxwell, Lauren Fishbein, Michael W. McLane, Chiara Benedetto, Emilie Marion Canuto, Nandita Mitra, Lin Zhang, Katherine L. Nathanson, Janos L. Tanyi

Published May 14, 2016 · Vol. 7, No. 30 · pp. 48577-48585

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia Priority Research Paper

Prognostic value of total lesion glycolysis of baseline ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma Research Paper

A network meta-analysis for toxicity of eight chemotherapy regimens in the treatment of metastatic/advanced breast cancer Research Paper

Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors Clinical Research Papers

Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era Research Paper

Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis Research Paper

Acrolein preferentially damages nucleolus eliciting ribosomal stress and apoptosis in human cancer cells Research Paper

Response to apatinib in chemotherapy-failed advanced spindle cell breast carcinoma Case Report

Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study Research Paper

A 5-day cytoreductive chemotherapy followed by haplo-identical hsct (FA5-BUCY) as a tumor-ablative regimen improved the survival of patients with advanced hematological malignancies Research Paper

A phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL Clinical Research Papers

The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome Research Paper

Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer Research Paper

Genetic polymorphisms and response to 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients Research Paper

PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas Research Paper

Thromboxane A2 receptor (TBXA2R) is a potent survival factor for triple negative breast cancers (TNBCs) Research Paper

Chemo-immunotherapy induces tumor regression in a mouse model of spontaneous mammary carcinogenesis Research Paper

Definitive activation of endogenous antitumor immunity by repetitive cycles of cyclophosphamide with interspersed Toll-like receptor agonists Research Paper

BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma models Research Paper

Paclitaxel is necessary for improved survival in epithelial ovarian cancers with homologous recombination gene mutations Clinical Research Papers

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia Priority Research Paper

Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma Research Paper

A network meta-analysis for toxicity of eight chemotherapy regimens in the treatment of metastatic/advanced breast cancer Research Paper

Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors Clinical Research Papers

Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era Research Paper

Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis Research Paper

Acrolein preferentially damages nucleolus eliciting ribosomal stress and apoptosis in human cancer cells Research Paper

Response to apatinib in chemotherapy-failed advanced spindle cell breast carcinoma Case Report

Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study Research Paper

A 5-day cytoreductive chemotherapy followed by haplo-identical hsct (FA5-BUCY) as a tumor-ablative regimen improved the survival of patients with advanced hematological malignancies Research Paper

A phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL Clinical Research Papers

The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome Research Paper

Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer Research Paper

Genetic polymorphisms and response to 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients Research Paper

PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas Research Paper

Thromboxane A2 receptor (TBXA2R) is a potent survival factor for triple negative breast cancers (TNBCs) Research Paper

Chemo-immunotherapy induces tumor regression in a mouse model of spontaneous mammary carcinogenesis Research Paper

Definitive activation of endogenous antitumor immunity by repetitive cycles of cyclophosphamide with interspersed Toll-like receptor agonists Research Paper

BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma models Research Paper

Paclitaxel is necessary for improved survival in epithelial ovarian cancers with homologous recombination gene mutations Clinical Research Papers

Prognostic value of total lesion glycolysis of baseline ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma Research Paper